130 related articles for article (PubMed ID: 26829682)
1. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.
Zielinski V; Laban S; Tribius S; Schafhausen P; Veldhoen S; Knecht R; Clauditz T; Muenscher A
Ear Nose Throat J; 2016 Jan; 95(1):23-8. PubMed ID: 26829682
[TBL] [Abstract][Full Text] [Related]
2. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
[TBL] [Abstract][Full Text] [Related]
3. Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy.
Ansari M; Guo S; Fakhri S; Citardi MJ; Blanco A; Patino M; Buryanek J; Amato R; Karni R; Brown RE
Ann Clin Lab Sci; 2013; 43(1):45-53. PubMed ID: 23462605
[TBL] [Abstract][Full Text] [Related]
4. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck.
Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024
[TBL] [Abstract][Full Text] [Related]
5. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Kuo P; Manes RP; Schwam ZG; Judson BL
Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
[TBL] [Abstract][Full Text] [Related]
9. Sinonasal undifferentiated carcinoma: Institutional trend toward induction chemotherapy followed by definitive chemoradiation.
London NR; Mohyeldin A; Daoud G; Gamez ME; Blakaj D; Bonomi M; Prevedello DM; Carrau RL
Head Neck; 2020 Nov; 42(11):3197-3205. PubMed ID: 32681692
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of advanced maxillary sinus squamous carcinoma: an analysis of 92 cases].
Su YR; Wu GH; Zeng ZY; Guo ZM; Chen WK; Wei MW; Chen YF
Ai Zheng; 2008 May; 27(5):535-8. PubMed ID: 18479606
[TBL] [Abstract][Full Text] [Related]
11. Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation.
Fried D; Zanation AM; Huang B; Hayes N; Morris DE; Rosenman J; Varia M; Funkhouser W; Weissler M; Chera BS
Laryngoscope; 2012 Oct; 122(10):2210-5. PubMed ID: 22886723
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative chemoradiation for sinonasal undifferentiated carcinoma of the anterior nasal cavity resected through a lateral nasal flap approach.
Surapaneni B; Kadakia S; Slupchynskyj O; Iacob C; Holliday R
Am J Otolaryngol; 2016; 37(2):120-4. PubMed ID: 26954865
[TBL] [Abstract][Full Text] [Related]
13. Treatment modalities in sinonasal undifferentiated carcinoma: an analysis from the national cancer database.
Khan MN; Konuthula N; Parasher A; Genden EM; Miles BA; Govindaraj S; Iloreta AM
Int Forum Allergy Rhinol; 2017 Feb; 7(2):205-210. PubMed ID: 27717204
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report.
Watanabe S; Honma Y; Murakami N; Igaki H; Mori T; Hirano H; Okita N; Shoji H; Iwasa S; Takashima A; Kato K; Kobayashi K; Matsumoto F; Yoshimoto S; Itami J; Boku N
World J Clin Cases; 2019 Mar; 7(6):765-772. PubMed ID: 30968042
[TBL] [Abstract][Full Text] [Related]
15. Targeting
Robinson H; Green M; Radkar G; Ready N; Strickler J
Cancer Invest; 2021 Mar; 39(3):235-239. PubMed ID: 33538211
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-cisplatin-radiotherapy in adenoid cystic carcinoma with high-grade transformation.
Handra-Luca A; Planchard D; Fouret P
Oral Oncol; 2009 Nov; 45(11):e208-9. PubMed ID: 19502105
[No Abstract] [Full Text] [Related]
17. Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma.
Revenaugh PC; Seth R; Pavlovich JB; Knott PD; Batra PS
Am J Otolaryngol; 2011; 32(6):464-9. PubMed ID: 21041001
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ; Murphy BA; Raez LE; Cohen RB; Spaulding M; Tishler RB; Roth B; Viroglio Rdel C; Venkatesan V; Romanov I; Agarwala S; Harter KW; Dugan M; Cmelak A; Markoe AM; Read PW; Steinbrenner L; Colevas AD; Norris CM; Haddad RI;
N Engl J Med; 2007 Oct; 357(17):1705-15. PubMed ID: 17960013
[TBL] [Abstract][Full Text] [Related]
19. Complete response to immunotherapy in sinonasal undifferentiated carcinoma.
Denaro N; Merlano M; Numico G; Garrone O; Bossi P
Tumori; 2021 Dec; 107(6):NP101-NP104. PubMed ID: 34225515
[TBL] [Abstract][Full Text] [Related]
20. Oncologic management of sinonasal undifferentiated carcinoma.
Tyler MA; Holmes B; Patel ZM
Curr Opin Otolaryngol Head Neck Surg; 2019 Feb; 27(1):59-66. PubMed ID: 30507692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
